Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Simvastatin for Bone Regeneration
NCT07031778Phase 1Recruiting
- Sponsor
- Universidad de Granada
- Start
- Jan 2025
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of simvastatin gel (Ain Shams University) in Alveolar bone loss (3 arms), sponsored by Universidad de Granada. Primary endpoint: Dimensional changes at 12 weeks. Started Jan 2025; status: recruiting.
02
Drugs
simvastatin gel (Ain Shams University)
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT07031778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07031778.